Pulmonary Disease Board Review app analytics for December 19

Pulmonary Disease Board Review

Pulmonary Disease Board Review

  • Usatine & Erickson Media LLC
  • Apple App Store
  • Paid
  • Medical
800 Q&A deliver a rigorous review for pulmonary board certification Part of the acclaimed McGraw-Hill Education Specialty Board Review series, this well-illustrated review is essential for pulmonary medicine physicians preparing for board certification or recertification. The coverage mirrors the board exam outline of the American Board of Internal Medicine (ABIM), focusing specifically on the most commonly tested topics in obstructive lung disease, critical care, diffuse parenchymal lung disease, sleep medicine, infections, and neoplasms. Offering more illustrations than similar reviews, Pulmonary Disease Examination and Board Review delivers authoritative coverage of the key concepts tested on the certification exam, including: making a diagnosis, test ordering and interpretation, treatment recommendations, understanding epidemiologic studies, understanding pathophysiology, and applying basic science knowledge to clinical situations. Features: • Case-based presentation mirrors the exam format • Includes numerous high-quality images, including: x-rays, CT scans, and electrocardiograms • Excellent as clinical refresher in pulmonary medicine This app is very intuitive and easy to navigate, allowing you to browse the contents or search for topics. The powerful search tool gives you word suggestions that appear in the text as you type, so it is lightning fast and helps with spelling those long medical terms. The search tool also keeps a recent history of past search terms so you can go back to a previous search result very easily. You can also change the text size for easier reading. Bookmark cases, add notes, answer multiple choice questions, view your statistics, and create customized tests on your way to mastering the content. After the app has been downloaded, no internet connection is needed to retrieve the content of the app. All of the text and images are available to you on your device anytime, anywhere, and lightning fast. This app is also automatically optimized for whatever size device you are currently using, either phone or tablet. Check out https://usatinemedia.com to learn more and watch a video demo of this app. This interactive app contains the full content of Pulmonary Disease Examination and Board Review by McGraw-Hill Education. ISBN-13: 978-0071845298 ISBN-10: 0071845291 Editor: Ronaldo Collo Go, MD Faculty Division of Pulmonary, Critical Care, and Sleep Medicine Mount Sinai Beth Israel New York, New York and Crystal Run Health Care Middletown, New York Disclaimer: This app is intended for the education of healthcare professionals and not as a diagnostic and treatment reference for the general population.     Developed by Usatine Media Richard P. Usatine, MD, Co-President, Professor of Family & Community Medicine, Professor of Dermatology and Cutaneous Surgery, University of Texas Health San Antonio Peter Erickson, Co-President, Lead Software Developer
Pulmonary Disease Board Review

Store Rank

The Store Rank is based on multiple parameters set by Google and Apple.

All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us

Pulmonary Disease Board Review Ranking Stats Over Time

Similarweb's Usage Rank & Apple App Store Rank for Pulmonary Disease Board Review

Rank

No Data Available

Pulmonary Disease Board Review Ranking by Country

Counties in which Pulmonary Disease Board Review has the highest ranking in its main categories

No Data to Display

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

Thoracic Imaging Fundamentals

Thoracic Imaging Fundamentals

BestApps BV

USMLE STEP 1 QUESTION BANK

USMLE STEP 1 QUESTION BANK

Abdulkarim Nasir

Lung Nodule Tracker

Lung Nodule Tracker

Zain Lateef

Radiology - CRC Staging Atlas

Radiology - CRC Staging Atlas

BestApps BV

Pulmonary Disease Board Review VS.

December 19, 2024